Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 4Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 3Microarray Analysis 2midostaurin 1laromustine 1eltrombopag 1dexamethasone acetate 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Idarubicin 1Genetic Testing 1Gene Expression Profiling 1Gemtuzumab 1Daunorubicin 1DNA Methylation 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Basophilic, Acute × Gemtuzumab × Clear all
NCT00091234 2012-07-24

AML-19

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Unknown
279 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡